The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
Chronic allograft nephropathy is the most prevalent cause of graft dysfunction and failure. Its pathogenesis and treatment remains poorly defined. The calcineurin inhibitors, cyclosporine and tacrolimus, may play a role in the progressive loss of renal function in patients with chronic allograft nep...
Main Authors: | Matthew R Weir, Chiming Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2001-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203010020013201 |
Similar Items
-
Chronic Allograft Nephropathy
by: Jumani Abdul
Published: (2006-01-01) -
Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy
by: G.T. Moscoso-Solorzano, et al.
Published: (2009-05-01) -
Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway
by: Guo C, et al.
Published: (2020-11-01) -
Role of shear wave elastography in assessment of chronic allograft nephropathy
by: Nadine R. Barsoum, et al.
Published: (2022-04-01) -
A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts.
by: Daley, SR, et al.
Published: (2007)